Ruben Tommasi
6PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Sep 16, 2021
Rational design of a new antibiotic class for drug-resistant infections.Thomas F Durand-Reville, Alita A Miller, John P O'Donnell
|Jul 14, 2020
Discovery of an Orally Available Diazabicyclooctane Inhibitor (ETX0282) of Class A, C, and D Serine β-Lactamases.Thomas F Durand-Réville, Janelle Comita-Prevoir, Jing Zhang
|May 08, 2020
Pharmacokinetic/Pharmacodynamic Determination and Preclinical Pharmacokinetics of the β-Lactamase Inhibitor ETX1317 and Its Orally Available Prodrug ETX0282.John O'Donnell, Angela Tanudra, April Chen
|Apr 08, 2020
In Vitro Characterization of ETX1317, a Broad-Spectrum β-Lactamase Inhibitor That Restores and Enhances β-Lactam Activity against Multi-Drug-Resistant Enterobacteriales, Including Carbapenem-Resistant Strains.Alita A Miller, Adam B Shapiro, Sarah M McLeod
|Nov 30, 2018
Titrating Levels of TolC in E. coli: A Sensitive Approach to Quantifying Efflux.Ramkumar Iyer, Samir H Moussa, Ruben Tommasi
|Feb 28, 2018
Antibacterial Drug Discovery: Some Assembly Required.Rubén Tommasi, Ramkumar Iyer, Alita A Miller
Pageof 1
